<DOC>
	<DOCNO>NCT01736462</DOCNO>
	<brief_summary>The objective study evaluate effect corneal endothelial cell density ( cells/mmÂ² ) change 3 month mapracorat ophthalmic suspension , 3 % administer QID ( four time daily ) , 14 day healthy subject normal ophthalmic history .</brief_summary>
	<brief_title>Corneal Endothelial Cell Density Changes , When Mapracorat Ophthalmic Suspension 3 % , Administered 14 Days</brief_title>
	<detailed_description />
	<criteria>Must Pinhole visual acuity ( VA ) equal good 20/40 eye . Must good ocular health Subjects know hypersensitivity contraindication study drug component . Subjects currently require expect require treatment medication list disallowed medication per Disallowed Therapy section protocol . Any topical ophthalmic medication , include tear substitute discontinue study . Subjects monocular ( fellow eye absent fellow eye 's Pinhole VA bad 20/200 ) . Subjects history ocular surgery , anticipate ocular surgery either eye within study period . Presence significant ocular systemic disease Investigator determines could interfere study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>Cornea</keyword>
	<keyword>Endothelial cell density</keyword>
</DOC>